Redhill Biopharma Ltd (NASDAQ:RDHL)

6.21
Delayed Data
As of 4:00pm ET
 +0.09 / +1.47%
Today’s Change
4.30
Today|||52-Week Range
11.25
+20.82%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues12.0K6.9M3.0K101.3K
 
 
 
 
 
Cost of Goods Sold--1.0M0.00--
 
 
Depreciation And Amortization24.1K26.6K36.0K44.1K
 
 
 
 
 
 
Operating ExpensesGross Income--5.9M-33.0K--
 
 
 
General Expenses10.8M16.5M21.9M30.7M
 
 
 
 
 
Research And Development8.1M12.5M17.8M25.3M
 
 
 
 
 
Total Operating Expenses10.8M17.5M21.9M30.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.8M-10.6M-21.9M-30.6M
 
 
 
 
 
Extraordinary Credit54.1K197.2K887.7K1.2M
 
 
 
 
 
Extraordinary Charge0.00---100.0K-369.2K
 
 
 
Other Expenses90.2K-279.0K-211.9K27.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.7M-10.6M-21.1M-29.5M
 
 
 
 
 
Net Income-10.7M-10.6M-21.1M-29.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS6.2M8.7M11.1M12.9M
 
 
 
 
 
Shares To Calculate EPS Diluted6.2M8.7M11.2M12.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.70-$1.18-$1.90-$2.31
 
 
 
 
 
EPS Diluted-$1.70-$1.28-$1.90-$2.41